Results 181 to 190 of about 5,907 (232)
Down's syndrome screening with nuchal translucency [PDF]
The Lancet, 1996 1 Nicolaides KH, Sebire NJ, Snijders RJM, Johnson S. Down’s syndrome screening in the UK. Lancet 1996; 347: 906–07. 2 Macintosh McM, Wald NJ, Chard T, et al. Correction: the selective miscarriage of Down’s syndrome for 10 weeks of pregnancy. Br J Obstet Gynaecol 1995; 102: 798–801. 3 Hyett JA, Sebire NJ, Snijders RJM, Nicolaides KH.
Allan Hackshaw +2 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
First trimester fetal nuchal translucency
Current Opinion in Obstetrics and Gynecology, 1995This review examines the development of a new method of screening for Down's syndrome based on the combination of fetal nuchal translucency thickness, maternal age and maternal serum biochemistry at 10-14 weeks of gestation. This method can potentially identify more than 80% of affected fetuses for a false-positive rate of less than 5%.
Rosalinde J. M. Snijders +3 more
openaire +3 more sources
Feasibility of Nuchal Translucency in Triplet Pregnancies
Journal of Ultrasound in Medicine, 2004To assess the feasibility of nuchal translucency in triplets compared with singletons.Nuchal translucency thickness as part of routine first-trimester screening in the general population was compared between 3128 singleton pregnancies and 51 triplets (153 fetuses). Crown-rump length was also noted.
Yuval Yaron +6 more
openaire +3 more sources
Ethical dimensions of nuchal translucency screening [PDF]
Clinics in Perinatology, 2003 First-trimester screening for NT, when conducted according to accepted standards of quality, is a reliable diagnostic screen. There is no compelling beneficence-based argument opposed to offering it, and offering it is an important autonomy-enhancing strategy. Screening should be offered only in centers where high quality is available. In our view, the
Stephen T. Chasen, Daniel W. Skupski
openaire +2 more sources
2018
All women should be offered prenatal screening or diagnostic testing for aneuploidy, regardless of maternal age, but with the increasing number of prenatal screening options now available, deciding which is the most appropriate test is increasingly complex.
Mary E. D'Alton, Jennifer M. Walsh
openaire +2 more sources
All women should be offered prenatal screening or diagnostic testing for aneuploidy, regardless of maternal age, but with the increasing number of prenatal screening options now available, deciding which is the most appropriate test is increasingly complex.
Mary E. D'Alton, Jennifer M. Walsh
openaire +2 more sources
Nuchal translucency and the heart
2011Introduction 264The nuchal scan 266Management 268Nuchal translucency describes sonolucent tissue in the posterior aspect of the fetal neck; the size can be measured with accuracy during the 1st trimester of pregnancy and an increase in the measurement is associated with an increased risk of chromosomal abnormality.
Nick Archer, Nicky Manning
openaire +1 more source
Vanishing nuchal translucency syndrome
jpme, 2009No abstract ...
Ozgur Deren, Ahmet Basaran
openaire +2 more sources
Nuchal translucency measurement in normal fetuses
Obstetrics & Gynecology, 1995To construct a normal range for the nuchal translucency measurement in chromosomally and phenotypically normal fetuses between 9 and 14 weeks' gestation.The nuchal translucency was measured prospectively in 771 chromosomally normal fetuses of women attending our antenatal clinic or prenatal diagnosis center.
Ben W.J. Mol +4 more
openaire +3 more sources
Nuchal Translucency in the First Trimester
Australian and New Zealand Journal of Obstetrics and Gynaecology, 1993Summary: All fetuses reported as having nuchal (nape of the neck) thickening or translucency detected by a first trimester ultrasound at 2 centres were reviewed to determine the incidence of aneuploidy. Twenty nine pregnancies were registered, amongst which 12 (41%) had an abnormal karyotype, the most common aneuploidy being trisomy 21 (5 fetuses ...
openaire +3 more sources
Increased nuchal translucency and CATCH 22
Prenatal Diagnosis, 1998Recent developments in cytogenetics has shown that 22q11 microdeletion is related to a broad spectrum of malformations which are described under the acronym CATCH 22 (Cardiac, Abnormal faces, Thymic hypoplasia, Cleft palate, Hypocalcaemia and 22 chromosome deletion).
M. S. Lazanakis +2 more
openaire +3 more sources